Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19901104rdf:typepubmed:Citationlld:pubmed
pubmed-article:19901104lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:19901104lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:19901104lifeskim:mentionsumls-concept:C1516985lld:lifeskim
pubmed-article:19901104lifeskim:mentionsumls-concept:C0684224lld:lifeskim
pubmed-article:19901104lifeskim:mentionsumls-concept:C1335110lld:lifeskim
pubmed-article:19901104lifeskim:mentionsumls-concept:C0006118lld:lifeskim
pubmed-article:19901104lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:19901104lifeskim:mentionsumls-concept:C0205618lld:lifeskim
pubmed-article:19901104lifeskim:mentionsumls-concept:C1334505lld:lifeskim
pubmed-article:19901104lifeskim:mentionsumls-concept:C0025723lld:lifeskim
pubmed-article:19901104lifeskim:mentionsumls-concept:C0086860lld:lifeskim
pubmed-article:19901104lifeskim:mentionsumls-concept:C0070167lld:lifeskim
pubmed-article:19901104lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:19901104lifeskim:mentionsumls-concept:C0220901lld:lifeskim
pubmed-article:19901104lifeskim:mentionsumls-concept:C0681890lld:lifeskim
pubmed-article:19901104lifeskim:mentionsumls-concept:C1522673lld:lifeskim
pubmed-article:19901104pubmed:issue35lld:pubmed
pubmed-article:19901104pubmed:dateCreated2009-12-9lld:pubmed
pubmed-article:19901104pubmed:abstractTextO6-methylguanine-methyltransferase (MGMT) promoter methylation has been shown to predict survival of patients with glioblastomas if temozolomide is added to radiotherapy (RT). It is unknown if MGMT promoter methylation is also predictive to outcome to RT followed by adjuvant procarbazine, lomustine, and vincristine (PCV) chemotherapy in patients with anaplastic oligodendroglial tumors (AOT).lld:pubmed
pubmed-article:19901104pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19901104pubmed:languageenglld:pubmed
pubmed-article:19901104pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19901104pubmed:citationSubsetIMlld:pubmed
pubmed-article:19901104pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19901104pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19901104pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19901104pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19901104pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19901104pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19901104pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19901104pubmed:statusMEDLINElld:pubmed
pubmed-article:19901104pubmed:monthDeclld:pubmed
pubmed-article:19901104pubmed:issn1527-7755lld:pubmed
pubmed-article:19901104pubmed:authorpubmed-author:FrenayMarcMlld:pubmed
pubmed-article:19901104pubmed:authorpubmed-author:DinjensWinand...lld:pubmed
pubmed-article:19901104pubmed:authorpubmed-author:SansonMarcMlld:pubmed
pubmed-article:19901104pubmed:authorpubmed-author:JeukenJudith...lld:pubmed
pubmed-article:19901104pubmed:authorpubmed-author:KrosJohan MJMlld:pubmed
pubmed-article:19901104pubmed:authorpubmed-author:BrandesAlba...lld:pubmed
pubmed-article:19901104pubmed:authorpubmed-author:TaphoornMarti...lld:pubmed
pubmed-article:19901104pubmed:authorpubmed-author:GorliaThierry...lld:pubmed
pubmed-article:19901104pubmed:authorpubmed-author:van den...lld:pubmed
pubmed-article:19901104pubmed:authorpubmed-author:DubbinkHendri...lld:pubmed
pubmed-article:19901104pubmed:authorpubmed-author:LacombeDenisDlld:pubmed
pubmed-article:19901104pubmed:authorpubmed-author:HegiMonikaMlld:pubmed
pubmed-article:19901104pubmed:authorpubmed-author:IbdaihAhmedAlld:pubmed
pubmed-article:19901104pubmed:authorpubmed-author:van der...lld:pubmed
pubmed-article:19901104pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19901104pubmed:day10lld:pubmed
pubmed-article:19901104pubmed:volume27lld:pubmed
pubmed-article:19901104pubmed:ownerNLMlld:pubmed
pubmed-article:19901104pubmed:authorsCompleteYlld:pubmed
pubmed-article:19901104pubmed:pagination5881-6lld:pubmed
pubmed-article:19901104pubmed:dateRevised2010-12-14lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:meshHeadingpubmed-meshheading:19901104...lld:pubmed
pubmed-article:19901104pubmed:year2009lld:pubmed
pubmed-article:19901104pubmed:articleTitleMGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.lld:pubmed
pubmed-article:19901104pubmed:affiliationDepartment of Neuro-Oncology and Pathology, Daniel den Hoed Cancer Center and Erasmus University Medical Center, Rotterdam, the Netherlands. m.vandenbent@erasmusmc.nllld:pubmed
pubmed-article:19901104pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19901104pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:19901104pubmed:publicationTypeMulticenter Studylld:pubmed
entrez-gene:4255entrezgene:pubmedpubmed-article:19901104lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19901104lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19901104lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19901104lld:pubmed